Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 4 February to Question 109206 on breast cancer drugs, if he will make it his policy to reform the risk-reducing drug pathway for patients at increased risk of breast cancer .

The Department is taking steps to ensure that women at increased risk of breast cancer are provided with the best information, support, preventative care, and testing.

Through our National Cancer Plan, we will develop and deliver more proactive approaches to identifying people at risk of cancer, through symptomatic case finding, additional support for general practitioners (GPs) and genomic testing. The new and world-leading NHS National Inherited Cancer Predisposition Registry, part of the National Disease Registration Service, will help the National Health Service to deliver proactive, targeted prevention, surveillance, and earlier diagnosis for people and their families. Self-testing swabs will accelerate access to genomic tests, and those who need it will get genetic counselling, regular surveillance checks, and prophylactic treatment options. For women at increased risk of breast cancer, this means a more proactive approach and personalised support.

Through our National Cancer Plan, and our wider work on improving GP services, we will offer improved support to women at increased risk of breast cancer.